| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
MK 0434
1
relevant articles (0 outcomes,
1 trials/studies)
found for this Bio-Agent
Description: a 4-azasteroid; structure given in first source
Also Known As:17 beta-benzoyl-4-aza-5 alpha-androst-1-ene-3-one; MK 434; MK-0434; MK-434
Bio-Agent Context: Research Results
Related Diseases
| 1. | Weight Loss (Weight Reduction)
01/01/2005
- "During the second half of the study, ORX rats lost an average of 18.86 +/- 4.62 g body wt. T completely prevented weight loss, and the effect was not inhibited by MK-434 (P < 0.001)"
Get all the results and reference details, order at left... |
| 2. | Bone Resorption
01/01/2005
- "Finally, T caused a 65% decrease in urine excretion of deoxypyridinoline, a marker of bone resorption, and again the effect was not blocked by MK-434 (P < 0.0001)"
Get all the results and reference details, order at left... |
| 2 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | deoxypyridinoline
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |